Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Pharma News, Views & Analysis
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
Biden-Harris Administration expands access to sickle cell disease treatments
In a victory for people with sickle cell disease, the US government has announced a major step towards improving access to treatment.
Read more
Warner Biddle takes top job at Kyverna Therapeutics
Warner Biddle has been appointed as CEO, Kyverna Therapeutics, following the resignation of Peter Maag this week.
Roche's twice-yearly MS injection wins FDA approval
The FDA has approved Roche’s subcutaneous injection for relapsing multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS).
Company reputation key to HCP prescribing decisions
New research shows that healthcare professionals consider a company’s leadership in a specific disease area and its overall reputation to be influential in prescribing decisions.
FDA lifts partial clinical hold on Rezolute hyperinsulinism treatment
The lift is based on new research showing that the previous adverse effects in laboratory rats may not have been caused by the drug itself.
New AI-focused RNA collaboration for Eli Lilly
Eli Lilly has entered into a research collaboration with Genetic Leap, a private company focused on AI, to advance the development of RNA-based genetic medicines.
NICE endorses Novartis’ take home drug for rare blood disorder
NICE recommends an oral therapy for adults with PNH, marking the 1000th medicine evaluated since its inception in 1999.
Sanofi's MS drug delivers surprising Phase III results
It’s been both a good and bad week for French pharmaceutical company Sanofi, as their MS drug candidate, received mixed trial results.
Second mpox vaccine wins FDA approval
The FDA has formally approved Emergent BioSolutions’ smallpox and mpox vaccine for use in preventing the virus in people at high risk of infection.
Loading posts...
« Previous
1
…
4
5
6
7
8
…
18
Next »